Top Markets
Coin of the day
HLS Therapeutics Inc. HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS
Clasificación en acciones #22602
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Precio por acción
$2.75
Última sincronización: 2026-08-21
Capitalización bursátil
$86.08M
Cambio (1 día)
-3.85%
Cambio (1 año)
-27.06%
País
CA
Comercio HLS Therapeutics Inc. (HLS)

Categoría

Historial del precio de la acción de HLS Therapeutics Inc. (HLS)
Precio más alto de cierre: $2.84 el 2026-08-01

Precio más bajo de cierre: $8.95 el 2018-03-01
Historial del precio de la acción de HLS Therapeutics Inc. desde 2018 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -2.35%
2025 38.06%
2024 -5.73%
2023 -63.25%
2022 -36.71%
2021 -13.17%
2020 -7.23%
2019 30.14%
2018 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN